New insights into molecular mechanisms of sunitinib-associated side effects. - Wikidata - awgldk - TriplyDB

New insights into molecular mechanisms of sunitinib-associated side effects.

New insights into molecular mechanisms of sunitinib-associated side effects.

http://www.wikidata.org/entity/Q37967571

about

An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma Combining radiotherapy with sunitinib: lessons (to be) learned PET Metabolic Biomarkers for Cancer BioGPS: The Music for the Chemo- and Bioinformatics Walzer.Analysis of adverse events of sunitinib in patients treated for advanced renal cell carcinoma.Uncommon side effect with a commonly used targeted agent: sunitinib-induced nephrotic syndrome in a patient with metastatic renal cell carcinoma.The use of targeted therapies in pancreatic neuroendocrine tumours: patient assessment, treatment administration, and management of adverse events.Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast Cancer Dual modulation of MCL-1 and mTOR determines the response to sunitinib.Clinical significance of sunitinib-associated macrocytosis in metastatic renal cell carcinoma.Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumors.2-Indolinone a versatile scaffold for treatment of cancer: a patent review (2008-2014).Polypharmacology: in silico methods of ligand design and development.Targeted Therapies in Thyroid Cancer: An Extensive Review of the Literature.Role of sunitinib and SU12662 on dermatological toxicities in metastatic renal cell carcinoma patients: in vitro, in vivo, and outcomes investigation.Development of chronic myeloid leukaemia in patients treated with anti-VEGF therapies for clear cell renal cell cancer.Disseminated intravascular coagulation following administration of sunitinib.Guillain-Barré Syndrome following Treatment with Sunitinib Malate.Incidence of bowel wall oedema on computed tomography exams and association with diarrhoea in renal cell carcinoma patients treated with sunitinib.Development and plasticity of meningeal lymphatic vessels.Targeting Myeloid-Derived Suppressor Cells in Cancer.[Side effect management of tyrosine kinase inhibitors in urology : Hypertension].[Side effect management of tyrosine kinase inhibitors in urology : Gastrointestinal side effects].Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR-2 inhibitor in metastatic breast cancer.

P2860

Q26784091-4BF07E2B-CF59-41A5-8927-CADF40FC86C4 Q26800587-F2C437EB-5B61-4901-AC2A-56A8A874E617 Q28074449-834FC51D-36E9-4A1D-9D86-B3512F9F35D8 Q30391391-DC5AB3E4-1FCF-4348-89F5-C3C40DE76BCA Q33432282-17E954F4-4FFC-4A22-9E16-516BFCD815D0 Q33691188-AC44914B-264A-49CD-BA36-C50B076FDA80 Q37117596-FFC1E34D-5C5B-49B7-A0ED-3EF433E5B089 Q37214094-353A5725-0D1B-408E-B798-4A3ED02899C7 Q37544978-61EEA7AB-09DE-458B-8C88-B79DB40039F2 Q37577963-E76B6CD6-BFC3-4735-AFDF-D3F94C7A834C Q38099390-10E3A974-5CB0-43F4-B460-407A7EE8D18E Q38631566-E6B3C009-EE27-4B4F-B9F0-8E542039B2A8 Q38814901-21E15EEE-1599-417E-B27D-E90922CB4DA7 Q38883187-8142C537-318F-40A6-801F-2CD9BF12AC89 Q39048761-81D57C40-BEF7-4D25-AB0B-BAE3701131C8 Q39172001-3D5A44C1-04DE-4F67-9C75-06E012A850E5 Q40688319-9AD6F5ED-942E-4273-9555-4786BEF0E80D Q41465130-6FF134DD-7491-4175-B8EF-59E5B6467DA4 Q42200105-4EF1682F-7578-4B2C-82B6-CD99EC8B1E40 Q47344702-B9FC549C-7712-4564-BF58-51189B8DBAAC Q47765346-B119CD2A-904B-4101-BBD0-A0DAFF5D4D81 Q54195816-A9CD75C8-FF73-4E0D-9770-D61EC94DAA6D Q54196218-38E43957-8A6B-4A88-A1DD-AD39CA2B7CB9 Q54344097-EB0A7D32-53BC-4549-B747-C630596A34FF

P2860

New insights into molecular mechanisms of sunitinib-associated side effects.

http://www.wikidata.org/entity/Q37967571

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

New insights into molecular mechanisms of sunitinib-associated side effects.

@en

New insights into molecular mechanisms of sunitinib-associated side effects.

@nl

type

label

New insights into molecular mechanisms of sunitinib-associated side effects.

@en

New insights into molecular mechanisms of sunitinib-associated side effects.

@nl

prefLabel

New insights into molecular mechanisms of sunitinib-associated side effects.

@en

New insights into molecular mechanisms of sunitinib-associated side effects.

@nl

P1433

Q37967571-D549BDE8-53A4-4539-99E8-271996526A76

P1476

Q37967571-2A7A8F04-A95B-4F81-B0B1-304BB2AD6016

P2093

Q37967571-1EF6FBF6-CAB5-45FD-9B0D-A76A1DA01B5F

Q37967571-4C33ACAD-36E5-46E7-96EC-C22B47038971

Q37967571-4F76E934-52F3-4455-85C6-93A7B1FD4098

Q37967571-79074D8F-93DD-4FEA-AD99-6F90EBEEE938

Q37967571-8C268C82-7A08-439B-B604-D062256AC05E

Q37967571-A2599ADC-4AE6-4CE0-AFB6-D4DEA42ED8BC

Q37967571-B60C2553-7F39-45F4-B1EB-F7B82CD27406

P304

Q37967571-74572128-EFB1-4786-B1BC-0404EC847C93

P31

Q37967571-837760C0-7991-4FD9-A872-E9CEA0C01686

P356

Q37967571-18273BB2-4A7E-4695-A3E8-DFB5712D9B97

P433

Q37967571-35BB5993-AA91-4F75-BED7-A881474C47C0

P478

Q37967571-8FA314EC-B046-45B7-9D64-B04F3241D029

P577

Q37967571-FCA39381-A35B-45B7-A6FE-FA2161DC41EE

P698

Q37967571-F004E306-0ABF-4747-BB10-2ACA6C263FED

P356

1535-7163.MCT-10-1124

P1433

Molecular Cancer Therapeutics

P1476

New insights into molecular mechanisms of sunitinib-associated side effects.

@en

P2093

Angélica Figueroa

http://www.w3.org/2001/XMLSchema#string

Enrique Grande-Pulido

http://www.w3.org/2001/XMLSchema#string

Guadalupe Aparicio-Gallego

http://www.w3.org/2001/XMLSchema#string

Luis Antón-Aparicio

http://www.w3.org/2001/XMLSchema#string

Manuel Valladares-Ayerbes

http://www.w3.org/2001/XMLSchema#string

Moisés Blanco

http://www.w3.org/2001/XMLSchema#string

Rosario García-Campelo

http://www.w3.org/2001/XMLSchema#string

P304

2215-2223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1535-7163.MCT-10-1124

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22161785

http://www.w3.org/2001/XMLSchema#string